Please login to the form below

Not currently logged in
Email:
Password:

Indoco and Watson Pharma in deal

Indian company Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market

Indoco Remedies has signed a deal with US-based Watson Pharmaceuticals to develop generic products for the US market.

Shares of the Mumbai-based Indoco surged 4.95 per cent on the Bombay Stock Exchange after the announcement.

Under this deal, Indoco will develop, manufacture and supply a number of products that currently have yearly sales of $679m.

Indoco's chairman and managing director Suresh G Kare has said it is a remarkable achievement to be out-licensing technology to a company of Watson's scale.

2nd February 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics